TY  - CHAP
M1  - Book, Section
TI  - Prevention of Venous Thromboembolism
A1  - Kalra, Smita Kohli
A2  - Cohn, Steven L.
PY  - 2021
T2  - Decision Making in Perioperative Medicine: Clinical Pearls
AB  - Venous  thromboembolism  (VTE),  which  includes  pulmonary  embolism  (PE)  and  deep  venous  thrombosis  (DVT),  is  a  serious  and  costly  complication  after  surgery.  It  affects  an  estimated  300,000–600,000  individuals  in  the  U.S.  each  year,  causing  considerable  morbidity  and  mortality.1  Approximately  25%  of  VTE  occur  in  patients  who  have  been  hospitalized  for  surgery,  and  this  number  will  likely  be  higher  if  silent  VTE  is  included.  Sudden  death  may  be  the  initial  presentation  in  a  quarter  of  the  patients  with  PE,  therefore  prevention  is  the  key.1  Other  potential  consequences  of  VTE  include  recurrence,  postthrombotic  syndrome,  pulmonary  hypertension,  and  right  heart  failure.  Despite  the  availability  of  effective  VTE  prophylaxis,  it  remains  underutilized  in  patients  undergoing  major  surgical  procedures.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1179530631
ER  -